Name Nandrolone Phenylpropionate+Decanoate
Classes Steroid
Anabolic Steroid
Diseases

Nandrolone Phenylpropionate+Decanoate

Nandrolone Phenylpropionate + Decanoate is a combination of two anabolic steroids. Nandrolone Phenylpropionate and Decanoate are synthetic derivatives of testosterone. They exert their effects by binding to and activating specific androgen receptors in various tissues, promoting protein synthesis, increasing nitrogen retention, and enhancing muscle growth.

 

Nandrolone Phenylpropionate + Decanoate is indicated for the treatment of:

  • Anemia associated with renal insufficiency
  • Red blood cell production stimulation in patients undergoing renal dialysis
  • Adjunctive therapy in select cases of mammary carcinoma

 

A dose of 50 to 100 mg per week is recommended for women and 100 to 200 mg per week for men. Drug therapy should be discontinued if no hematologic improvement is seen within the first six months. For children from 2 to 13 years of age, the average dose is 25 to 50 mg every 3 to 4 weeks. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever the solution and container permit.

 

The following side effects have been seen in patients receiving Nandrolone Phenylpropionate + Decanoate therapy-

  • Virilization (development of male characteristics in females)
  • Edema (fluid retention)
  • Hepatotoxicity (liver damage)
  • Gastrointestinal disturbances (nausea, vomiting, diarrhea)
  • Suppression of natural testosterone production
  • Skin reactions (acne, oily skin)
  • Changes in libido (increase or decrease)
  • Behavioral changes (mood swings, aggression)
  • Cardiovascular effects (increased blood pressure, changes in lipid profile)
  • Allergic reactions (rare)

 

  • Virilization: In female patients, the use of Nandrolone Phenylpropionate + Decanoate can lead to the development of masculine characteristics. Dose adjustment or discontinuation may be necessary if signs of virilization occur.
  • Liver function: Regular monitoring of liver function is advised due to the potential hepatotoxic effects of the medication.
  • Cardiovascular effects: Nandrolone Phenylpropionate + Decanoate may cause changes in blood pressure, cholesterol levels, and cardiovascular risk factors. Monitoring of blood pressure and lipid profiles is recommended during treatment.
  • Psychiatric effects: Patients with a history of psychiatric disorders may be at an increased risk of experiencing behavioral changes, including mood swings and aggression.
  • Prostate cancer: Use with caution in patients with a history of prostate cancer or suspected prostate malignancy, as androgenic compounds may stimulate the growth of prostate tissue.
  • Fluid retention: Patients with conditions such as heart failure or renal impairment may experience worsened fluid retention while using Nandrolone Phenylpropionate + Decanoate.

 

Contraindication

Nandrolone Phenylpropionate + Decanoate.is contraindicated in patients with hypersensitivity to any component of the medication.

Nandrolone Phenylpropionate + Decanoate is contraindicated in the following situations-

  • Male patients with carcinoma of the breast or with known or suspected carcinoma of the prostate.
  • Carcinoma of the breast in females with hypercalcemia: androgenic anabolic steroids may stimulate osteolytic resorption of bones.
  • Pregnancy, because of masculinization of the fetus.
  • Nephrosis or the nephrotic phase of nephritis.